Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Effects of reduced insulin-2 in beta cells of NOD mice
EF 2021-22
Résumé
Type
1 Diabetes (T1D) is a disease that affects ~1% of Canadians and is
characterized by the death of insulin-producing beta cells within the
pancreas. Insulin is an essential protein that triggers cells to absorb
digested sugar (glucose) from the bloodstream for energy and storage. As
the body’s only source of circulating insulin, beta cell death in T1D
traps glucose in the blood and cells are starved of energy. Genetic
predispositions are known to contribute to T1D by causing the body’s
immune system to attack and destroy beta cells (autoimmunity). However,
recent research has shown that beta cell stress and subsequent dysfunction
may also have a role in beta cell death. Insulin production is a complex
process which can stress beta cells. This stress increases the likelihood
of faulty insulin production, which can cause the cell to activate suicide
pathways, and possibly trigger an autoimmune reaction against these
dysfunctional beta cells. We
propose that decreasing insulin production will alleviate stress, thereby
increasing beta cell survival and delaying diabetes onset. We plan to test
this hypothesis by using mice predisposed to develop T1D and genetically
reduce insulin production levels by injecting a beta cell-specific viral
vector carrying an insulin-gene modifier. We will monitor diabetes
incidence in the mice and measure biomarkers for beta cell stress and
autoimmunity. While
no cure currently exists for T1D, enhanced screening technology enables
earlier detection of pre-diabetic patients. Understanding why beta cells
die is essential to the development of future therapeutics. Preventative
medicine could prolong beta cell survival and help maintain natural
insulin production, changing the outcome of T1D predisposition.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
481149
Name
Nahirney Natalie
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effects of reduced insulin-2 in beta cells of NOD mice
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmunity; Beta Cell; Diabetes; Er Stress; Gene Reduction; Nod Mice; Type 1 Diabetes
Abstract
<html>
<head>
</head>
<body>
<span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none"><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px">Type
1 Diabetes (T1D) is a disease that affects ~1% of Canadians and is
characterized by the death of insulin-producing beta cells within the
pancreas. Insulin is an essential protein that triggers cells to absorb
digested sugar (glucose) from the bloodstream for energy and storage. As
the body’s only source of circulating insulin, beta cell death in T1D
traps glucose in the blood and cells are starved of energy.</font></span><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px"><br align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">Genetic
predispositions are known to contribute to T1D by causing the body’s
immune system to attack and destroy beta cells (autoimmunity). However,
recent research has shown that beta cell stress and subsequent dysfunction
may also have a role in beta cell death. Insulin production is a complex
process which can stress beta cells. This stress increases the likelihood
of faulty insulin production, which can cause the cell to activate suicide
pathways, and possibly trigger an autoimmune reaction against these
dysfunctional beta cells.</span><br align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">We
propose that decreasing insulin production will alleviate stress, thereby
increasing beta cell survival and delaying diabetes onset. We plan to test
this hypothesis by using mice predisposed to develop T1D and genetically
reduce insulin production levels by injecting a beta cell-specific viral
vector carrying an insulin-gene modifier. We will monitor diabetes
incidence in the mice and measure biomarkers for beta cell stress and
autoimmunity.</span><br align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)"><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">While
no cure currently exists for T1D, enhanced screening technology enables
earlier detection of pre-diabetic patients. Understanding why beta cells
die is essential to the development of future therapeutics. Preventative
medicine could prolong beta cell survival and help maintain natural
insulin production, changing the outcome of T1D predisposition.</span></font>
</body>
</html>
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nahirney, Natalie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~